GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (STU:5HB) » Definitions » Net Cash per Share

Shanghai Haohai Biological Technology Co (STU:5HB) Net Cash per Share : €0.64 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Shanghai Haohai Biological Technology Co's Net Cash per Share for the quarter that ended in Jun. 2024 was €0.64.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's Net Cash per Share or its related term are showing as below:

STU:5HB' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.96   Med: 4.69   Max: 9.79
Current: 5.28

During the past 10 years, the highest Price-to-Net-Cash Ratio of Shanghai Haohai Biological Technology Co was 9.79. The lowest was 1.96. And the median was 4.69.

STU:5HB's Price-to-Net-Cash is ranked worse than
55.49% of 838 companies
in the Biotechnology industry
Industry Median: 4.27 vs STU:5HB: 5.28

Shanghai Haohai Biological Technology Co Net Cash per Share Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Net Cash per Share Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.16 0.94 0.65 0.69

Shanghai Haohai Biological Technology Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.69 0.70 0.64 -

Competitive Comparison of Shanghai Haohai Biological Technology Co's Net Cash per Share

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Price-to-Net-Cash falls into.



Shanghai Haohai Biological Technology Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Shanghai Haohai Biological Technology Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(353.315-139.756-47.162)/240.068
=0.69

Shanghai Haohai Biological Technology Co's Net Cash per Share for the quarter that ended in Jun. 2024 is calculated as

Net Cash per Share (Q: Jun. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(350.646-151.92-47.079)/235.49
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co  (STU:5HB) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Shanghai Haohai Biological Technology Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Shanghai Haohai Biological Technology Co Headlines

No Headlines